A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00645229 · TERMINATED
Trial details
- NCT number
- NCT00645229
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.